Free Float 0,18 %
Shares Float 5,04 M
Shares Outstanding 6,04 M
180 LIFE SCIENCES CORP - WARRANT
Share · US68236V1127 · ATNFW (XNAS)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of 180 LIFE SCIENCES CORP - WARRANT
No Price
Share Float & Liquidity
Company Profile for 180 LIFE SCIENCES CORP - WARRANT Share
180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.
Company Data
Name 180 LIFE SCIENCES CORP - WARRANT
Company ETHZilla Corporation Warrant
Symbol ATNFW
Website
http://www.180lifesciences.com
Primary Exchange 
NASDAQ
NASDAQ
ISIN US68236V1127
Asset Class Share
Sector Healthcare
Industry Medical - Pharmaceuticals
CEO Lloyd Blair Jordan
Country United States of America
Currency USD
Employees 0,0 T
Address Building 4, 94306 Palo Alto
IPO Date 2017-06-27
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | ATNFW |
More Shares
Investors who hold 180 LIFE SCIENCES CORP - WARRANT also have the following shares in their portfolio:
